Frequency of Metabolic Syndrome in Patients with Hepatitis C Virus Infection
DOI:
https://doi.org/10.54112/bcsrj.v6i6.1891Keywords:
Blood Glucose, Hepatitis C, Chronic, Metabolic Syndrome, Obesity, Risk FactorsAbstract
Hepatitis C virus (HCV) infection is a major global health burden, traditionally associated with chronic liver disease. Objective: To determine the frequency of metabolic syndrome in patients with chronic hepatitis C virus infection and assess its association with demographic and clinical variables. Methods: This cross-sectional observational study was conducted at the Department of General Medicine, AIMC/Jinnah Hospital, Lahore, from March 2025 to May 2025. A total of 220 patients aged 20–60 years with confirmed HCV infection were enrolled using non-probability consecutive sampling. Demographic data, clinical examination findings, and laboratory results, including fasting blood glucose, triglycerides, HDL cholesterol, and blood pressure, were recorded. Results: The mean age of patients was 42.7 ± 10.2 years; 124 (56.4%) were male and 96 (43.6%) were female. Metabolic syndrome was identified in 49 patients (22.3%). Significant associations were found between MetS and age ≥45 years (p = 0.04) as well as BMI ≥25 kg/m² (p < 0.001). No significant association was observed between MetS and duration of HCV infection (p = 0.12). Conclusion: It is concluded that metabolic syndrome is a frequent comorbidity in patients with chronic HCV infection, particularly among older and overweight individuals. Routine screening for metabolic risk factors in HCV patients is recommended to facilitate early intervention and reduce associated cardiovascular and hepatic complications.
Downloads
References
Negro F, Alaei M. Hepatitis C virus and type 2 diabetes. World J Gastroenterol. 2009 May 28;15(13):1537-47. https://doi.org/10.3748/wjg.15.1537
White DL, Ratziu V, El-Serag HB. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. Hepatology. 2008 Nov;49(3):831-44. https://doi.org/10.1002/hep.22744
Umar M, Bushra HT, Ahmad M, Khurrum M, Usman S, Arif M, et al. Hepatitis C in Pakistan: a review of available data. Hepat Mon. 2010;10(3):205-14. PMID: 22312364; PMCID: PMC3269109
Pattullo V. Hepatitis C and diabetes: one treatment for two diseases? Liver Int. 2016 Jan;36 Suppl 1:23-6. https://doi.org/10.1111/liv.13004
Lonardo A, Adinolfi LE, Petta S, Craxì A, Loria P. Hepatitis C and diabetes: the inevitable coincidence? Expert Rev Anti Infect Ther. 2009 Mar;7(3):293-308. https://doi.org/10.1586/eri.09.3
Sheikh H, Karira KA, Rahuv AA, Sheikh QH, Sheikh Y, Rani M. Risk of type II diabetes in viral hepatitis B/C patients. J Liaquat Univ Med Health Sci. 2011;10(1):11-4.
Kotronen A, Yki-Järvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):27-38. https://doi.org/10.1161/ATVBAHA.107.147538
Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Clin Gastroenterol Hepatol. 2010 Oct;8(10):1410-6. https://doi.org/10.1016/j.cgh.2010.08.012
Cacoub P, Carrat F, Bedossa P, Lambert J, Perronne C, Pol S, et al. Insulin resistance impairs sustained virological response rate to pegylated interferon plus ribavirin in HIV–hepatitis C virus co-infected patients. Antivir Ther. 2008;13(6):839-45. PMID: 18839780
Huang JF, Chuang WL, Yu ML, Yu SH, Huang CF, Huang CY, et al. Hepatitis C virus infection and metabolic syndrome: a community-based study in an endemic area of Taiwan. Kaohsiung J Med Sci. 2009 Jun;25(6):299-305. https://doi.org/10.1016/S1607-551X(09)70526-5
Bashir MI, Ashraf J, Anwar T. Metabolic syndrome in cases with hepatitis C virus infection. J Sheikh Zayed Med Coll. 2017;8(4):1273-6.
Qasim SF, Jami A, Imran P, Mushtaque R, Khan RN. Frequency of metabolic syndrome in chronic hepatitis C patients: findings from a lower-middle-income country. Cureus. 2020 Dec 8;12(12):e11975. https://doi.org/10.7759/cureus.11975
Munawar RZ, Nazar T, Aziz B, Yousaf MK, Mohsin N, Nawaz K. Prevalence of metabolic syndrome in hepatitis B virus infection. Pak J Health Sci. 2024;5(10):101-4. https://doi.org/10.54393/pjhs.v5i10.2144
Kuo YH, Kee KM, Wang JH, Hsu NT, Hsiao CC, Chen Y, et al. Association between chronic viral hepatitis and metabolic syndrome in southern Taiwan: a large population-based study. Aliment Pharmacol Ther. 2018 Nov;48(9):993-1002. https://doi.org/10.1111/apt.14960
Rajkumar P, Dwivedi AK, Dodoo CA, S hokar NK, Salinas J, Lakshmanaswamy R. The association between metabolic syndrome and hepatitis C virus infection in the United States. Cancer Causes Control. 2020 Jun;31(6):569-81. https://doi.org/10.1007/s10552-020-01300-5
Zhou J, Gao Q, Wang J, Zhang M, Ma J, Wang C, et al. Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China. BMJ Open. 2018 Oct 25;8(10):e022974. https://doi.org/10.1136/bmjopen-2018-022974
Ambrosino P, Lupoli R, Di Minno A, Tarantino L, Spadarella G, Tarantino P, et al. The risk of coronary artery disease and cerebrovascular disease in patients with hepatitis C: a systematic review and meta-analysis. Int J Cardiol. 2016 Oct 15;221:746-54. https://doi.org/10.1016/j.ijcard.2016.06.337
Flisiak R, Pogorzelska J, Flisiak-Jackiewicz M. Hepatitis C: efficacy and safety in real life. Liver Int. 2017 Jan;37 Suppl 1:26-32. https://doi.org/10.1111/liv.13293
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Hafiz Abdul Basit Khan, Samina Saeed, Talha Khalid, Sidrah Muhammad Rafiq, Numan Ahmed, Abdullah Khan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
